1. Home
  2. MDGL vs AMKR Comparison

MDGL vs AMKR Comparison

Compare MDGL & AMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • AMKR
  • Stock Information
  • Founded
  • MDGL 2011
  • AMKR 1968
  • Country
  • MDGL United States
  • AMKR United States
  • Employees
  • MDGL N/A
  • AMKR N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • AMKR Semiconductors
  • Sector
  • MDGL Health Care
  • AMKR Technology
  • Exchange
  • MDGL Nasdaq
  • AMKR Nasdaq
  • Market Cap
  • MDGL 6.8B
  • AMKR 6.1B
  • IPO Year
  • MDGL N/A
  • AMKR 1998
  • Fundamental
  • Price
  • MDGL $290.09
  • AMKR $19.80
  • Analyst Decision
  • MDGL Strong Buy
  • AMKR Buy
  • Analyst Count
  • MDGL 10
  • AMKR 7
  • Target Price
  • MDGL $420.63
  • AMKR $26.67
  • AVG Volume (30 Days)
  • MDGL 382.7K
  • AMKR 2.2M
  • Earning Date
  • MDGL 05-01-2025
  • AMKR 04-28-2025
  • Dividend Yield
  • MDGL N/A
  • AMKR 3.63%
  • EPS Growth
  • MDGL N/A
  • AMKR N/A
  • EPS
  • MDGL N/A
  • AMKR 1.28
  • Revenue
  • MDGL $317,383,000.00
  • AMKR $6,273,756,000.00
  • Revenue This Year
  • MDGL $264.55
  • AMKR $1.79
  • Revenue Next Year
  • MDGL $67.21
  • AMKR $6.24
  • P/E Ratio
  • MDGL N/A
  • AMKR $15.70
  • Revenue Growth
  • MDGL N/A
  • AMKR N/A
  • 52 Week Low
  • MDGL $200.08
  • AMKR $14.03
  • 52 Week High
  • MDGL $377.46
  • AMKR $44.86
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 35.76
  • AMKR 62.13
  • Support Level
  • MDGL $280.68
  • AMKR $17.18
  • Resistance Level
  • MDGL $307.54
  • AMKR $20.28
  • Average True Range (ATR)
  • MDGL 16.00
  • AMKR 0.57
  • MACD
  • MDGL -2.91
  • AMKR 0.37
  • Stochastic Oscillator
  • MDGL 3.19
  • AMKR 83.56

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About AMKR Amkor Technology Inc.

Amkor Technology Inc is a provider of outsourced semiconductor packaging and test services to integrated device manufacturers, fabless semiconductor companies, and contract foundries. The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.

Share on Social Networks: